Skip to main content
. Author manuscript; available in PMC: 2017 Mar 14.
Published in final edited form as: Pharmacotherapy. 2016 Mar 14;36(3):263–272. doi: 10.1002/phar.1717

Table 4. Incidence (per 100 person-years) of Major Hemorrhage by CYP4F2 genotype.

CYP4F2 genotype N Events FU
years
Incidence Incidence rate
ratio
P
Value
All
*1/*1 784 92 1099.5 8.37 (6.75 -10.26) Reference
*1/*3 390 44 554.6 7.93 (5.76-10.65) 0.95 (0.66 -13.53) 0.85
*3/*3 64 4 107.5 3.72 (1.00-9.53) 0.44 (0.14-1.10) 0.09
European Americans
*1/*1 340 36 504.0 7.14 (5.00-9.89) Reference
*1/*3 305 35 438.2 7.99 (5.56-11.11) 1.12 (0.70-1.79) 0.64
*3/*3 62 4 103.8 3.85 (1.04-9.87) 0.54 (0.16-1.40) 0.24
African Americans
*1/*1 444 56 595.5 9.40 (7.10-12.21) Reference
*1/*3 85 9 116.4 7.73 (3.53-14.68) 0.82 (0.38-1.61) 0.61
*3/*3 2 0 3.7

CYP4F2 genotype (*1/*1 or *1/*3 versus *3/*3)

All
*1/*1 or *1/*3 1174 136 1654.1 8.22 (6.89 -9.73) Reference
*3/*3 64 4 107.5 3.72 (1.00-9.53) 0.45 (0.14-1.11) 0.09
European Americans
*1/*1 or *1/*3 645 71 942.2 7.54 (5.89-9.51) Reference
*3/*3 62 4 103.8 3.85 (1.04-9.87) 0.51 (0.16-1.28) 0.22
African Americans
*1/*1 or *1/*3 529 65 711.9 9.13 (7.10-11.56)
*3/*3 2 0 3.7

CYP4F2 genotype (*1/*1 versus *1/*3 or *3/*3)

All
*1/*1 784 92 1099.5 8.37 (6.75 -10.26) Reference
*1/*3 or *3/*3 454 48 662.1 7.25 (5.35-9.61) 0.87 (0.61-1.22) 0.42
European Americans
*1/*1 340 36 504.0 7.14 (5.00-9.89) Reference
*1/*3 or *3/*3 367 39 542.0 7.20 (5.12-9.84) 1.01 (0.64-1.59) 0.98
African Americans
*1/*1 444 56 595.5 9.40 (7.10-12.21) Reference
*1/*3 or *3/*3 87 9 120.1 7.49 (3.42-14.23) 0.80 (0.37-1.56) 0.55

FU years: Follow-up years